Role of Measurable Residual Disease (MRD) Testing for the Prediction of Late Relapses Following Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

被引：0
|
作者：
Ali, Naveed [1 ]
Megan, Othus [2 ]
Rodriguez-Arboli, Eduardo [3 ]
Orvain, Corentin [3 ]
Milano, Filippo [3 ]
Sandmaier, Brenda M. [3 ]
Davis, Chris [1 ]
Basom, Ryan S. [1 ]
Appelbaum, Frederick R. [1 ]
Walter, Roland B. [4 ,5 ,6 ]
机构：
[1] Fred Hutchinson Canc Ctr, Div Clin Res, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, Div Publ Hlth Sci, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[4] Fred Hutchinson Canc Res Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[5] Univ Washington, Dept Med, Div Hematol, Seattle, WA USA
[6] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Gang, Margery
    Othus, Megan
    Walter, Roland B.
    CELLS, 2025, 14 (04)
  • [2] The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
    Czyz, Anna
    Nagler, Arnon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [3] Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
    Eduardo Rodríguez-Arbolí
    Corentin Orvain
    Megan Othus
    Roland B. Walter
    Bone Marrow Transplantation, 2022, 57 : 1732 - 1734
  • [4] Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
    Rodriguez-Arboli, Eduardo
    Orvain, Corentin
    Othus, Megan
    Walter, Roland B.
    BONE MARROW TRANSPLANTATION, 2022, 57 (11) : 1732 - 1734
  • [5] Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Stahl, Maximilian
    Derkach, Andriy
    Famulare, Christopher
    Cho, Christina
    Devlin, Sean
    Farnoud, Noushin
    Menghrajani, Kamal
    Patel, Minal A.
    Cai, Sheng F.
    Geyer, Mark B.
    Dunbar, Andrew
    Epstein-Peterson, Zachary D.
    McGovern, Erin
    Schulman, Jessica
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Stein, Eytan M.
    Getta, Bartlomiej
    Arcila, Maria E.
    Levine, Ross L.
    Barker, Juliet
    Shaffer, Brian C.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Perales, Miguel-Angel
    Abdel-Wahab, Omar
    Papaemmanuil, Elli
    Giralt, Sergio A.
    Zhang, Yanming
    Roshal, Mikhail
    Tallman, Martin S.
    Goldberg, Aaron D.
    BLOOD, 2020, 136
  • [6] Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?
    El Chaer, Firas
    Ballen, Karen K.
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1473 - 1474
  • [7] Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?
    Firas El Chaer
    Karen K. Ballen
    Bone Marrow Transplantation, 2022, 57 : 1473 - 1474
  • [8] Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
    Alexander P. Hoffmann
    Ashley L. Besch
    Megan Othus
    Linde M. Morsink
    Brent L. Wood
    Marco Mielcarek
    Elihu H. Estey
    Frederick R. Appelbaum
    Roland B. Walter
    Bone Marrow Transplantation, 2020, 55 : 669 - 672
  • [9] Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
    Hoffmann, Alexander P.
    Besch, Ashley L.
    Othus, Megan
    Morsink, Linde M.
    Wood, Brent L.
    Mielcarek, Marco
    Estey, Elihu H.
    Appelbaum, Frederick R.
    Walter, Roland B.
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 669 - 672
  • [10] Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
    Rodriguez-Arboli, Eduardo
    Othus, Megan
    Orvain, Corentin
    Zarling, Lucas C.
    Sandmaier, Brenda M.
    Milano, Filippo
    Schoch, Gary
    Davis, Chris
    Deeg, H. Joachim
    Appelbaum, Frederick R.
    Storb, Rainer
    Walter, Roland B.
    HAEMATOLOGICA, 2023, 108 (01) : 273 - 277
12345